Unknown PHASE2 INTERVENTIONAL 2-arm NCT03279796

Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells

Autologous Adipose-derived Mesenchymal Stem Cells in the Treatment of Tendon Disease: a Randomized Controlled Trial

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions Lateral Epicondylitis Rotator Cuff Tear

Interventions Autologous adipose-derived MSCs Compound betamethasone

Updated 7 times since 2017 Last updated: Apr 24, 2018 Started: Oct 1, 2018 Primary completion: Dec 31, 2019 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lateral Epicondylitis and Rotator Cuff Tear, this trial is ongoing. The trial is conducted by Second Affiliated Hospital, School of Medicine, Zhejiang University and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE2
Jun 2018 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

▶ Show 2 earlier versions

May 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2
Oct 2017 — May 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University
Zhejiang Xingyue Biotechnology Co., Ltd.

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China